Edition:
India

Japan Tobacco - Top-Line Results Of Phase 3 Clinical Study Of Riona In Adult Patients With Iron Deficiency Anemia In Japan


Tuesday, 9 Jul 2019 

July 9 (Reuters) - Japan Tobacco Inc <2914.T>::TOP-LINE RESULTS OF PHASE 3 CLINICAL STUDY OF RIONA IN ADULT PATIENTS WITH IRON DEFICIENCY ANEMIA IN JAPAN.RESULTS SHOW STUDY MET PRIMARY ENDPOINT.JT AND TORII PHARMACEUTICAL WILL AIM TO FILE FOR ADDITIONAL INDICATION OF IMPROVING IDA FOR RIONA IN JAPAN BASED ON THIS AND OTHER CLINICAL STUDIES. 

Company Quote

2320.5
22.5 +0.98%
11:30am IST